Clinical Trials Directory

Trials / Completed

CompletedNCT00731068

Platelet Rich Plasma (PRP) as a Treatment for ACHILLES Tendon Tears

PRP as a Treatment for ACHILLES Tendon Tears - Randomized-Double-Blind-Placebo Control Trail

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

To review the influence of patient derived PRGF on the healing process of Achilles tendon after a surgical correction of a complete tear.

Detailed description

Autologous platelet-rich matrices may aid in post surgical patients by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPRGFinjection of 6cc into injured area of tendon
BIOLOGICALplaceboinjection of 6 cc of saline into injured area

Timeline

Start date
2007-02-01
Primary completion
2009-02-01
Completion
2009-03-01
First posted
2008-08-08
Last updated
2013-10-24

Source: ClinicalTrials.gov record NCT00731068. Inclusion in this directory is not an endorsement.

Platelet Rich Plasma (PRP) as a Treatment for ACHILLES Tendon Tears (NCT00731068) · Clinical Trials Directory